Live feed
Filing
SCHEDULE 13G
SCHEDULE 13G0001426156-26-000005·ClearPoint Neuro, Inc.
Schedule 13G ownership disclosure
ClearPoint Neuro Inc
Common Stock, $0.01 par value per share · CUSIP: 18507C103
Event date: 2026-03-10
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- MAK Capital Fund LP
Shares: 1,729,611.00 · Class: 6.1%
- MAK CAPITAL ONE LLC
Shares: 1,729,611.00 · Class: 6.1%
- Kaufman Michael A
Shares: 1,729,611.00 · Class: 6.1%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001426156-26-000005
- Form type
- SCHEDULE 13G
- Filer
- ClearPoint Neuro, Inc.
- CIK
- CIK 1285550
- Filed
- Mar 13, 2026
- Reporting period
- Mar 10, 2026
- Description
- Schedule 13G beneficial ownership